Low-Dose Topical 5-Aminolevulinic Acid Photodynamic Therapy in the Treatment of Different Severity of Acne Vulgaris. (Q50238436)

28 February 2018

title

Low-Dose Topical 5-Aminolevulinic Acid Photodynamic Therapy in the Treatment of Different Severity of Acne Vulgaris. (English)

1 reference

28 February 2018

1 reference

Shi-Qin Tao

1

1 reference

28 February 2018

Fei Li

2

1 reference

28 February 2018

Lei Cao

3

1 reference

28 February 2018

Ru-Shan Xia

4

1 reference

28 February 2018

Hua Fan

5

1 reference

28 February 2018

Ying Fan

6

1 reference

28 February 2018

Hui Sun

7

1 reference

28 February 2018

Cheng Jing

8

1 reference

28 February 2018

Li-Jia Yang

9

1 reference

28 February 2018

publication date

1 December 2015

1 reference

28 February 2018

Cell Biochemistry and Biophysics

published in

1 reference

28 February 2018

volume

73

1 reference

28 February 2018

issue

3

1 reference

28 February 2018

page(s)

701-706

1 reference

28 February 2018

https://scigraph.springernature.com/pub.10.1007/s12013-015-0627-3

exact match

0 references

cites work

Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0627-3

Therapy for acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0627-3

Psychologic Aspects of Acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0627-3

Current and future treatment options for acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0627-3

A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0627-3

Topical ALA-photodynamic therapy for the treatment of acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0627-3

A review of progress in clinical photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0627-3

Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0627-3

Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part II. Understanding parameters for acne treatment with photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0627-3

Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0627-3

Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0627-3

Prospective study of topical 5-aminolevulinic acid photodynamic therapy for the treatment of moderate to severe acne vulgaris in Chinese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0627-3

Low-dose topical 5-aminolevulinic acid photodynamic therapy in the treatment of different severity of acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0627-3

Investigation of optimal aminolaevulinic acid concentration applied in topical aminolaevulinic acid-photodynamic therapy for treatment of moderate to severe acne: a pilot study in Chinese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0627-3

Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0627-3

10.1007/S12013-015-0627-3

21 January 2018

Identifiers

DOI

1 reference

28 February 2018

PubMed ID

27259313

1 reference

28 February 2018